Abstract:Background: Endometriosis (EM) is a common gynecological disorder that often leads to irregular menstruation and infertility. The pathogenesis of EM remains unclear and delays in diagnosis are common. Thus, it is urgent to explore potential biomarkers and underlying molecular mechanisms for EM diagnosis and therapies. Methods: Three EM-related datasets (GSE11691, GSE25628, and GSE86534) were downloaded from the Gene Expression Omnibus (GEO) which were integrated into a combined dataset after removing batch effect. Differentially expressed immune cell-related genes were obtained by CIBERSORT, WGCNA, and the identification of differentially expressed genes. Random forest model (RF), support vector machine model (SVM), and generalized linear model (GLM) were then constructed and the biomarkers for EM were determined. A nomogram evaluating the risk of disease was constructed and the validity was assessed by the calibration curve, DCA curve, and clinical impact curve. Single-gene Gene Set Enrichment Analysis (GSEA)was performed to explore the molecular mechanisms of biomarkers. The ceRNA regulatory network of biomarkers was created by Cytoscape and potential target drugs were obtained in the DGIdb database (Drug-Gene Interaction database).The expression levels of biomarkers from clinical samples was quantified by RT-qPCR. Results: The ratio of eight immune cells was significantly different between the eutopic and ectopic endometrium samples. A total of eight differentially expressed immune cell-related genes were investigated. The SVM model was a relatively suitable model for the prediction of EM and five genes (CXCL12, PDGFRL, AGTR1, PTGER3, and S1PR1) were selected from the model as biomarkers. The calibration curve, DCA curve, and clinical impact curve indicated that the nomogram based on the five biomarkers had a robust ability to predict disease. Single gene GSEA result suggested that all five biomarkers were involved in labyrinthine layer morphogenesis and transmembrane transport-related biological processes in EM. A ceRNA regulatory network containing 184 nodes and 251 edges was constructed. Seven drugs targeting CXCL12, 49 drugs targeting AGTR1, 16 drugs targeting PTGER3, and 21 drugs targeting S1PR1 were extracted as potential drugs for EM therapy. Finally, the expression of PDGFRL and S1PR1 in clinical samples was validated by RT-qPCR, which was consistent with the result of public database. Conclusions: In summary, we identified five biomarkers (CXCL12, PDGFRL, AGTR1, PTGER3, and S1PR1) and constructed diagnostic model, furthermore predicted the potential therapeutic drugs for EM. Collectively, these findings provide new insights into EM diagnosis and treatment.

Expression of Programmed Death-1 (PD-1) and Its Ligand PD-L1 is Upregulated in Endometriosis and Promoted by 17Beta-Estradiol

Identification of Key Genes and Pathways in Endometriosis by Integrated Expression Profiles Analysis.

Pgpm_a_354957 377..392

Peripheral Immune Regulation in the Pathogenesis of Endometriosis

Posttranscriptional Control of PD-L1 Expression by 17Β-Estradiol Via PI3K/Akt Signaling Pathway in ERα-Positive Cancer Cell Lines.

Altered expression of interleukin-18 in the ectopic and eutopic endometrium of women with endometriosis

Expression of PD-1, PD-L1 and PD-L2 is Associated with Differentiation Status and Histological Type of Endometrial Cancer

Exosomes from the Uterine Cavity Mediate Immune Dysregulation via Inhibiting the JNK Signal Pathway in Endometriosis

Bioinformatics identification and validation of biomarkers and infiltrating immune cells in endometriosis

PDCD4 suppresses proliferation, migration and invasion of endometrial cells by inhibiting autophagy and NF-κB/MMP2/MMP9 signal pathway.

Macrophage-associated Immune Checkpoint CD47 Blocking Ameliorates Endometriosis.

Reduced microRNA-451 expression in eutopic endometrium contributes to the pathogenesis of endometriosis

Estrogen Receptor Beta Promotes Endometriosis Progression by Upregulating CD47 Expression in Ectopic Endometrial Stromal Cells.

Inhibition of IGF2BP1 attenuates the progression of endometriosis through PTBP1

NLRP3 activated macrophages promote endometrial stromal cells migration in endometriosis

Expression of Leptin and Leptin Receptor in Endometrium of Ectopic and Eutopic of Ovarian Endometriosis

The Expression of VEGF, ER, PR in Ectopic Endometrium and Eutopic Endometrium of EM Patients

Upregulation of Interleukin 35 in Patients with Endometriosis Stimulates Cell Proliferation

Expression of Survivin and MMP-9 in Eutopic Endometrium of Patients with Endometriosis

[Expression and Significance of ET-1 and Its Receptors in Endometriosis].

S100A7 Promotes the Development of Human Endometriosis by Activating NF‐κB Signaling Pathway in Endometrial Stromal Cells